180 related articles for article (PubMed ID: 24566949)
1. Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease.
Matusch A; Saft C; Elmenhorst D; Kraus PH; Gold R; Hartung HP; Bauer A
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1210-20. PubMed ID: 24566949
[TBL] [Abstract][Full Text] [Related]
2. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
Scahill RI; Zeun P; Osborne-Crowley K; Johnson EB; Gregory S; Parker C; Lowe J; Nair A; O'Callaghan C; Langley C; Papoutsi M; McColgan P; Estevez-Fraga C; Fayer K; Wellington H; Rodrigues FB; Byrne LM; Heselgrave A; Hyare H; Sampaio C; Zetterberg H; Zhang H; Wild EJ; Rees G; Robbins TW; Sahakian BJ; Langbehn D; Tabrizi SJ
Lancet Neurol; 2020 Jun; 19(6):502-512. PubMed ID: 32470422
[TBL] [Abstract][Full Text] [Related]
4. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
5. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
6. Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.
Dumas EM; Say MJ; Jones R; Labuschagne I; O'Regan AM; Hart EP; van den Bogaard SJ; Queller S; Justo D; Coleman A; Dar Santos RC; Dürr A; Leavitt BR; Tabrizi SJ; Roos RA; Stout JC
J Huntingtons Dis; 2012; 1(1):97-106. PubMed ID: 25063192
[TBL] [Abstract][Full Text] [Related]
7. Impaired postural stability as a marker of premanifest Huntington's disease.
Salomonczyk D; Panzera R; Pirogovosky E; Goldstein J; Corey-Bloom J; Simmons R; Gilbert PE
Mov Disord; 2010 Oct; 25(14):2428-33. PubMed ID: 20818666
[TBL] [Abstract][Full Text] [Related]
8. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
[TBL] [Abstract][Full Text] [Related]
9. Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease.
Stüwe SH; Goetze O; Lukas C; Klotz P; Hoffmann R; Banasch M; Orth M; Schmidt WE; Gold R; Saft C
Neurology; 2013 Feb; 80(8):743-6. PubMed ID: 23390182
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
11. Molecular Imaging in Huntington's Disease.
Wilson H; Politis M
Int Rev Neurobiol; 2018; 142():289-333. PubMed ID: 30409256
[TBL] [Abstract][Full Text] [Related]
12. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.
Boy C; Meyer PT; Kircheis G; Holschbach MH; Herzog H; Elmenhorst D; Kaiser HJ; Coenen HH; Haussinger D; Zilles K; Bauer A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):589-97. PubMed ID: 18000666
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.
Odish OF; van den Berg-Huysmans AA; van den Bogaard SJ; Dumas EM; Hart EP; Rombouts SA; van der Grond J; Roos RA;
Hum Brain Mapp; 2015 Jan; 36(1):110-9. PubMed ID: 25139578
[TBL] [Abstract][Full Text] [Related]
14. Progressive microstructural changes of the occipital cortex in Huntington's disease.
Odish OFF; Reijntjes RHAM; van den Bogaard SJA; Roos RAC; Leemans A
Brain Imaging Behav; 2018 Dec; 12(6):1786-1794. PubMed ID: 29492750
[TBL] [Abstract][Full Text] [Related]
15. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.
Meyer PT; Elmenhorst D; Boy C; Winz O; Matusch A; Zilles K; Bauer A
Neurobiol Aging; 2007 Dec; 28(12):1914-24. PubMed ID: 16996650
[TBL] [Abstract][Full Text] [Related]
16. Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease.
Gorges M; Müller HP; Mayer IM; Grupe GS; Kammer T; Grön G; Kassubek J; Landwehrmeyer GB; Wolf RC; Orth M
Sci Rep; 2017 Mar; 7():43841. PubMed ID: 28266655
[TBL] [Abstract][Full Text] [Related]
17. Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.
Achenbach J; Matusch A; Elmenhorst D; Bauer A; Saft C
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740281
[TBL] [Abstract][Full Text] [Related]
18. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
19. Current status of PET imaging in Huntington's disease.
Pagano G; Niccolini F; Politis M
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1171-82. PubMed ID: 26899245
[TBL] [Abstract][Full Text] [Related]
20. PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
Fazio P; Fitzer-Attas CJ; Mrzljak L; Bronzova J; Nag S; Warner JH; Landwehrmeyer B; Al-Tawil N; Halldin C; Forsberg A; Ware J; Dilda V; Wood A; Sampaio C; Varrone A;
Mov Disord; 2020 Apr; 35(4):606-615. PubMed ID: 31967355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
